Clinical Trials for Mesothelioma Patients: Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma Study Criteria
Read about the study criteria for patients with Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma . Please note: This information is provided by Weitz & Luxenberg for informational purposes only.
CriteriaDisease Characteristics:
Histologically or cytologically confirmed or radiographic evidence of primary non-small cell lung cancer, esophageal cancer, or malignant pleural mesothelioma
Intracranial metastases potentially treatable with surgery and/or radiotherapy allowed
Patient Characteristics:
ECOG performance status 0-2
Normal coagulation parameters
Prior Concurrent Therapy:
Not specified
If you or a loved one has been doagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.
Study criteria for patients with esophageal or mesothelioma cancer